Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
17 Results Found
Trailblazers: Small Things Matter in Infection Prevention
A new AHA Trailblazers report, “Small Things Matter in Infection Prevention,” explores how hospitals are expanding surveillance programs to include peripheral intravenous catheters (PIVCs) and other vascular access devices — an area that represents both high volume and untapped opportunity for infection prevention.
Small Things Matter in Infection Prevention
How hospitals expand infection prevention and surveillance to reduce bloodstream infections and improve patient safety. - TrailBlazers
Study: Two-dose antibiotic may be as effective as IV therapy for serious staph infections
A study published by JAMA Aug. 13 found that a two-dose antibiotic treatment could be just as effective as traditional long-term IV therapy for treating serious Staphylococcus aureus bloodstream infections.
Infection Control and Prevention
Healthcare-Associated Infections (HAI) prevention and reduction are longstanding quality and patient safety priorities.
What Is a CLABSI and How to Prevent It
In this episode of the Advancing Health podcast series, Nishant Prasad, M.D., attending physician and program director of infectious diseases at NewYork-Presbyterian Queens, shares how they re-approached CLABSI prevention by deeply examining structure and process, and how their work got them to zero CLABSIs in the last year.
Hospital Onset Bacteremia
Sources of hospital onset bacteremia (HOB), its identification, how effectively HOB can be prevented, treated and considerations for quality metrics.
CDC report shows decreases in certain health care-associated infections in 2023
The Centers for Disease Control and Prevention Nov. 6 released its annual progress report on health care-associated infections, which showed continued decreases in hospitalizations last year.
Henry Ford Health: Accelerating Efforts to Reduce CLABSI Rates Yields Promising Results
Henry Ford’s hematology-oncology unit has reduced the incidence of CLABSIs in its hematology-oncology unit by 75%, documenting only two cases between July 2020 and June 2021.
A Case Study in Reducing Central Line-Associated Bloodstream Infection (CLABSI) Rates
A Case Study in Reducing Central Line-Associated Bloodstream Infection (CLABSI) Rates